Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma. - Wikidata - awgldk - TriplyDB

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

http://www.wikidata.org/entity/Q39235262

about

Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology Clinical significance of sCD163 and its possible role in asthma (Review).Progress in aptamer-mediated drug delivery vehicles for cancer targeting and its implications in addressing chemotherapeutic challenges.Elevated soluble CD163 plasma levels are associated with disease severity in patients with hemorrhagic fever with renal syndrome Tumor-associated macrophages: from basic research to clinical application.Serum galectin-1 in patients with multiple myeloma: associations with survival, angiogenesis, and biomarkers of macrophage activation.Preoperative serum macrophage activated biomarkers soluble mannose receptor (sMR) and soluble haemoglobin scavenger receptor (sCD163), as novel markers for the diagnosis and prognosis of gastric cancer.Nurse-like cells impact on disease progression in chronic lymphocytic leukemia.Soluble CD163 as a prognostic biomarker in B-cell chronic lymphocytic leukemia.Tumor-associated macrophages and extracellular matrix metalloproteinase inducer in prognosis of multiple myeloma.CD163 as a novel target gene of STAT3 is a potential therapeutic target for gastric cancer.CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma.Prognostic role of M2 tumour-associated macrophages in lymphoproliferative disorders.Prognostic value of diametrically polarized tumor-associated macrophages in multiple myeloma.Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity.Antibody dependent cellular phagocytosis by macrophages is a novel mechanism of action of elotuzumab.Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis.

P2860

Q26799114-42BBE393-DB6E-4EE5-A664-74FFABB9B6F1 Q33674640-41207D7B-94CD-4849-98A2-C32DE133A956 Q33935498-003EE667-8349-4B82-9D3D-B9852A3AB3CC Q34505966-84D9049A-F1EB-458A-900F-195AA3CCD187 Q37671174-0052FCA6-DBB3-41D3-AC0C-9D5B7AF1C760 Q38824039-944B919D-97FD-4F58-AC20-E68B6432B417 Q41612982-0FB81E16-18C4-4833-B258-53A6D888AB32 Q42553277-C320D444-1AEE-4948-AB95-A4966D6DA961 Q43813493-240F6D67-8385-47FA-92C7-9DF9F1170C11 Q44890085-B329C14C-CCC4-4996-A75D-674E58B0AA9B Q45874696-3CFDFB26-3FA2-4C9D-9995-E041CE6344BD Q47125786-EA2B8049-25F0-4E49-AE5D-101EF33A7462 Q48201715-365848F8-A5EC-4686-852D-D3BF3D1123B0 Q48515598-FF9D9915-A378-48C9-B0DF-93255B76B81C Q49130713-FC54760C-9E7C-4356-968B-9942FE08B853 Q49954049-6257FB91-003C-44AC-A4F6-B35E714D7B7D Q50545382-8BC7DB3A-4997-48A0-BCEA-871C2B579EFD Q52589219-B0E21E8D-F3D4-4EAB-848C-F3402CB1E7B0 Q55340253-64A4D647-1D93-4727-9A0E-4D4091194F72

P2860

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

http://www.wikidata.org/entity/Q39235262

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

@en

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

@nl

type

label

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

@en

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

@nl

prefLabel

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

@en

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

@nl

P1433

Q39235262-AD427771-5BA0-44D1-BF86-385B1539DB41

P1476

Q39235262-DD117D35-AE32-488E-A3A2-E02B378ABC9E

P2093

Q39235262-1B4089B5-7271-4371-915D-7B30C5DE606A

Q39235262-341B77AC-D342-49C6-9CB2-E13846B77180

Q39235262-963D7ED7-0DB8-4820-90F7-BA105451F77C

Q39235262-B58ADBFB-9A15-4DED-92E1-05C5BAE01418

Q39235262-B630C47E-8A3E-4603-A13D-CDAE1D1B845D

P2860

Q39235262-06550021-91DF-4915-9C80-6989E1367915

Q39235262-1E921DCA-BEC4-4BA4-ABAF-420298520264

Q39235262-21A52D84-5D77-4DA2-8250-F31B84FB8C97

Q39235262-2BF967CB-867A-492F-A048-F26D1FCBC95E

Q39235262-4F232F8D-F034-4B1F-90D9-83AB7B2B4FCE

Q39235262-5D0D8D87-F7CB-40E1-9F63-F31F479509CF

Q39235262-6FAF262F-2A42-4FCB-99FD-4962AA2A1827

Q39235262-82245002-B7AD-4D23-9801-98F3B7E80533

Q39235262-8591B423-0587-496A-BE71-6BC89745F371

Q39235262-97BBAED7-48B1-4DED-BB8D-390CAD1546D4

P304

Q39235262-EAED8390-6B1C-4AB3-8AAA-08D965C98247

P31

Q39235262-67D1D6D0-C34A-4F7D-AE69-B98E927B23A0

P356

Q39235262-1484711E-1F5F-4709-A47C-35D156400D26

P433

Q39235262-2876643B-29AD-4201-BB09-3B8CDD059624

P478

Q39235262-7439E7D3-F028-4A31-9626-BD8BB9CECE6B

P577

Q39235262-47D8BE5F-B6A4-4483-A348-F23031B661EC

P698

Q39235262-4AC6FF8E-8E62-44DA-9040-5DA129ACFBEF

P921

Q39235262-2A7C6EB2-AD30-4DA7-8642-8BAD8247C956

Q39235262-2CBC773C-D313-43CE-8CA7-5DEBB8D22197

P356

P1433

European Journal of Haematology

P1476

Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.

@en

P2093

Holger J Møller

http://www.w3.org/2001/XMLSchema#string

Maciej B Maniecki

http://www.w3.org/2001/XMLSchema#string

Morten N Andersen

http://www.w3.org/2001/XMLSchema#string

Niels Abildgaard

http://www.w3.org/2001/XMLSchema#string

Niels F Andersen

http://www.w3.org/2001/XMLSchema#string

P2860

Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

Tumour-educated macrophages promote tumour progression and metastasis

Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm

Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trials.

CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response.

International staging system for multiple myeloma.

Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells.

Bone marrow microenvironment and the identification of new targets for myeloma therapy.

P304

41-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/EJH.12296

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

93

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24612259

http://www.w3.org/2001/XMLSchema#string

P921